Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/THIOGENESIS THERAPEUTICS CORP/ D

SEC Filing · D

THIOGENESIS THERAPEUTICS CORP

TTIPFOTCEQUITYCurrent

SEC Filing

Filed Nov 25, 2022Accepted Nov 25, 2022, 4:11 AM ESTCIK 1877778Accession 0001062993-22-022769
View company →Permanent SEC source ↗
Share

Company context

Current securities

TTIPFOTC · EQUITY · Current

Recent company filings

  1. D filingJun 9, 2026
  2. D filingAug 8, 2025
  3. D filingDec 20, 2023
  4. D filingAug 11, 2021

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗